- Advertisement -
NeuroScientific Biopharmaceuticals chief scientific advisor Dr Marian Sturm said: “Resolution of acute rejection in the majority of the small group of patients facing loss of their kidney was fantastic. The anti-inflammatory and immunomodulatory properties of StemSmart MSC brought the…
Click here to view the original article.

